Figure 2.
Injected hRBCs survive longer in HMOX-1–/– mice than in HMOX-1+/+ mice. Human RBCs were injected intraperitoneally into nonengrafted HMOX-1+/+ (n = 7) and HMOX-1–/– MSRG47 mice (n = 7). Mice were bled retro-orbitally at days 1, 2, 6, and 8 after injection and analyzed for human RBCs (hCD235a+) vs mouse RBCs (Ter-119+). (A) Number of hRBCs per microliter of blood. (B) Total RBCs (human and mouse) per microliter of blood.

Injected hRBCs survive longer in HMOX-1–/– mice than in HMOX-1+/+ mice. Human RBCs were injected intraperitoneally into nonengrafted HMOX-1+/+ (n = 7) and HMOX-1–/– MSRG47 mice (n = 7). Mice were bled retro-orbitally at days 1, 2, 6, and 8 after injection and analyzed for human RBCs (hCD235a+) vs mouse RBCs (Ter-119+). (A) Number of hRBCs per microliter of blood. (B) Total RBCs (human and mouse) per microliter of blood.

Close Modal

or Create an Account

Close Modal
Close Modal